SILVER SPRINGS, Md. –– An FDA advisory panel is recommending emergency use authorization for a second coronavirus vaccine.
The vaccine by Moderna is expected to get final approval in the next day or so. Trial studies found the two-dose vaccine around 95-percent effective.
With the expectation that the FDA will soon give the green light, vaccine advisers to the CDC scheduled meetings for Saturday and Sunday to discuss the Moderna vaccine.
The group must vote to recommend the vaccine and the CDC must accept that recommendation before vaccinations can begin.
“I think this is a very exciting moment,” Dr. Hayley Gans, a member of the FDA’s vaccine advisory committee, told CNN. “The data that was presented to us was striking in its efficacy.”
Last week, the FDA approved a COVID-19 vaccine by Pfizer for emergency use. Trials of Pfizer’s vaccine had similar results to Moderna’s.
